Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for recombinant proteins (compound)
Most Correlated Studies
- PBMCs from hepatitis C patients undergoing peg-interferon alfa 2b and ribavirin therapy
- Differential histological response to Alefacept in psoriasis patients
- Dendritic cells derived from bone marrow treated with synthetic lipopeptide vaccine Hp4 and HP10
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Most Relevant Literature
- The implementation of a design of experiments strategy to increase recombinant protein yields in yea…
- Recombinant protein production 6 (Vienna, February 2011).
- Optimising yeast as a host for recombinant protein production (review).
- Disruption of yeast cells to isolate recombinant proteins.
- Human cells: new platform for recombinant therapeutic protein production.
Most Relevant Clinical Trials
- Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study
- Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
- Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors
- Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2…
- Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
